Carrageenan-induced colitis is associated with decreased population of anti-inflammatory bacterium, Akkermansia muciniphila, in the gut microbiota of C57BL/6J mice

Toxicology Letters

Volumn 279, Issue , 2017, Pages 87-95

  Shang, Qingsen ^a   Sun, Weixia ^a   Shan, Xindi ^a   Jiang, Hao ^a   Cai, Chao ^a   Hao, Jiejie ^a   Li, Guoyun ^a   Yu, Guangli ^a,b  

^a OCEAN UNIVERSITY OF CHINA   (China)

^b QINGDAO NATIONAL LABORATORY FOR MARINE SCIENCE AND TECHNOLOGY   (China)

Author keywords

Akkermansia muciniphila; Carrageenan; Colitis; Gut microbiota; Inflammation

Indexed keywords

CARRAGEENAN; BACTERIAL DNA; IL10 PROTEIN, MOUSE; IL1B PROTEIN, MOUSE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN-6, MOUSE; TUMOR NECROSIS FACTOR;

AKKERMANSIA MUCINIPHILA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; HIGH THROUGHPUT SEQUENCING; INTESTINE FLORA; MICROBIAL COMMUNITY; MOUSE; NONHUMAN; PATHOGENESIS; POPULATION ABUNDANCE; PRIORITY JOURNAL; ANIMAL; BACTERIAL LOAD; BIOLOGY; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED; CLASSIFICATION; COLON; DISEASE MODEL; DNA SEQUENCE; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PROCEDURES; VERRUCOMICROBIA;

ANIMALS; BACTERIAL LOAD; CARRAGEENAN; COLITIS; COLON; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; DNA, BACTERIAL; GASTROINTESTINAL MICROBIOME; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE, INBRED C57BL; SEQUENCE ANALYSIS, DNA; TUMOR NECROSIS FACTOR-ALPHA; VERRUCOMICROBIA;

EID: 85026894737     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2017.07.904     Document Type: Article

References (50)

1. Belzer, C., De Vos, W.M., Microbes inside—from diversity to function: the case of Akkermansia. ISME J. 6 (2012), 1449–1458.
2. Bhattacharyya, S., Borthakur, A., Dudeja, P.K., Tobacman, J.K., Carrageenan reduces bone morphogenetic protein-4 (BMP4) and activates the Wnt/β-catenin pathway in normal human colonocytes. Digest Dis. Sci. 52 (2007), 2766–2774.
3. Bhattacharyya, S., Borthakur, A., Dudeja, P.K., Tobacman, J.K., Carrageenan induces cell cycle arrest in human intestinal epithelial cells in vitro. J. Nutr. 138 (2008), 469–475.
4. Bhattacharyya, S., Gill, R., Chen, M.L., Zhang, F., Linhardt, R.J., Dudeja, P.K., Tobacman, J.K., Toll-like receptor 4 mediates induction of the Bcl10-NFκB-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. J. Biol. Chem. 283 (2008), 10550–10558.
5. Bhattacharyya, S., O-sullivan, I., Katyal, S., Unterman, T., Tobacman, J.K., Exposure to the common food additive carrageenan leads to glucose intolerance, insulin resistance and inhibition of insulin signalling in HepG2 cells and C57BL/6. J. Mice Diabetologia 55 (2012), 194–203.
6. Borthakur, A., Bhattacharyya, S., Dudeja, P.K., Tobacman, J.K., Carrageenan induces interleukin-8 production through distinct Bcl10 pathway in normal human colonic epithelial cells. Am. J. Physiol-Gastr. L. 292 (2007), G829–G838.
7. Caffrey, S.M., Park, H.S., Been, J., Gordon, P., Sensen, C.W., Voordouw, G., Gene expression by the sulfate-reducing bacterium Desulfovibrio vulgaris Hildenborough grown on an iron electrode under cathodic protection conditions. Appl. Environ. Microb. 74 (2008), 2404–2413.
8. Chassaing, B., Koren, O., Goodrich, J.K., Poole, A.C., Srinivasan, S., Ley, R.E., Gewirtz, A.T., Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 519 (2015), 92–96.
9. Choi, H.J., Kim, J., Park, S.H., Do, K.H., Yang, H., Moon, Y., Pro-inflammatory NF-κB and early growth response gene 1 regulate epithelial barrier disruption by food additive carrageenan in human intestinal epithelial cells. Toxicol. Lett. 211 (2012), 289–295.
10. Cole, J.R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R.J., Kulam-Syed-Mohideen, A.S., McGarrell, D.M., Marsh, T., Garrity, G.M., et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic. Acids. Res. 37 (2009), D141–D145.
11. Derrien, M., Collado, M.C., Ben-Amor, K., Salminen, S., de Vos, W.M., The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl. Environ. Microb. 74 (2008), 1646–1648.
12. Gómez-Gallego, C., Pohl, S., Salminen, S., de Vos, W.M., Kneifel, W., Akkermansia muciniphila: a novel functional microbe with probiotic properties. Benef. Microbes 7 (2016), 571–584.
13. Garrett, W.S., Gallini, C.A., Yatsunenko, T., Michaud, M., DuBois, A., Delaney, M.L., Punit, S., Karlsson, M., Bry, L., Glickman, J.N., et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8 (2010), 292–300.
14. Gibson, G.R., Physiology and ecology of the sulphate-reducing bacteria. J. Appl. Microbiol. 69 (1990), 769–797.
15. Huang, J., Lin, X., Xue, B., Luo, J., Gao, L., Wang, Y., Ou, S., Peng, X., Impact of polyphenols combined with high-fat diet on rats' gut microbiota. J. Funct. Foods 26 (2016), 763–771.
16. Ignatova, M., Manolova, N., Rashkov, I., Markova, N., Quaternized chitosan/κ-carrageenan/caffeic acid–coated poly (3-hydroxybutyrate) fibrous materials: preparation, antibacterial and antioxidant activity. Int. J. Pharmaceut. 513 (2016), 528–537.
17. Kamada, N., Seo, S.U., Chen, G.Y., Núñez, G., Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 13 (2013), 321–335.
18. Kang, C.S., Ban, M., Choi, E.J., Moon, H.G., Jeon, J.S., Kim, D.K., Park, S.K., Jeon, S.G., Roh, T.Y., Myung, S.J., et al. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS One, 8, 2013.
19. Ling, Z., Liu, X., Jia, X., Cheng, Y., Luo, Y., Yuan, L., Wang, Y., Zhao, C., Guo, S., Li, L., et al. Impacts of infection with different toxigenic Clostridium difficile strains on faecal microbiota in children. Sci. Rep., 4, 2014, 7485.
20. Loubinoux, J., Bronowicki, J.P., Pereira, I.A., Mougenel, J.L., Le Faou, A.E., Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. FEMS Microbiol. Ecol. 40 (2002), 107–112.
21. Mallett, A.K., Rowland, I.R., Bearne, C.A., Nicklin, S., Influence of dietary carrageenans on microbial biotransformation activities in the cecum of rodents and on gastrointestinal immune status in the rat. Toxicol. Appl. Pharm. 78 (1985), 377–385.
22. Manichanh, C., Borruel, N., Casellas, F., Guarner, F., The gut microbiota in IBD. Nat. Rev. Gastro. Hepat. 9 (2012), 599–608.
23. McKim, J.M., Food additive carrageenan Part I: A critical review of carrageenan in vitro studies, potential pitfalls, and implications for human health and safety. Crit. Rev. Toxicol. 44 (2014), 211–243.
24. Necas, J., Bartosikova, L., Carrageenan: a review. Vet. Med. 58 (2013), 187–205.
25. Nicholson, J.K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., Pettersson, S., Host-gut microbiota metabolic interactions. Science 336 (2012), 1262–1267.
26. Oun, A.A., Rhim, J.W., Carrageenan-based hydrogels and films Effect of ZnO and CuO nanoparticles on the physical, mechanical, and antimicrobial properties. Food Hydrocolloid. 67 (2017), 45–53.
27. Png, C.W., Lindén, S.K., Gilshenan, K.S., Zoetendal, E.G., McSweeney, C.S., Sly, L.I., McGuckin, M.A., Florin, T.H., Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 105 (2010), 2420–2428.
28. Reunanen, J., Kainulainen, V., Huuskonen, L., Ottman, N., Belzer, C., Huhtinen, H., de Vos, W.M., Satokari, R., Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer. Appl. Environ. Microb. 81 (2015), 3655–3662.
29. Rey, F.E., Gonzalez, M.D., Cheng, J., Wu, M., Ahern, P.P., Gordon, J.I., Metabolic niche of a prominent sulfate-reducing human gut bacterium. Proc. Natl. Acad. Sci. USA 110 (2013), 13582–13587.
30. Round, J.L., Mazmanian, S.K., The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9 (2009), 313–323.
31. Salyers, A.A., Vercellotti, J.R., West, S.E., Wilkins, T.D., Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl. Environ. Microb. 33 (1977), 319–322.
32. Sekirov, I., Russell, S.L., Antunes, L.C.M., Finlay, B.B., Gut microbiota in health and disease. Physiol. Rev. 90 (2010), 859–904.
33. Shang, Q., Li, Q., Zhang, M., Song, G., Shi, J., Jiang, H., Cai, C., Hao, J., Li, G., Yu, G., Dietary keratan sulfate from shark cartilage modulates gut microbiota and increases the abundance of Lactobacillus spp. Mar. Drugs, 14, 2016, 224.
34. Shang, Q., Shan, X., Cai, C., Hao, J., Li, G., Yu, G., Dietary fucoidan modulates the gut microbiota in mice by increasing the abundance of Lactobacillus and Ruminococcaceae. Food Funct. 7 (2016), 3224–3232.
35. Shang, Q., Shi, J., Song, G., Zhang, M., Cai, C., Hao, J., Li, G., Yu, G., Structural modulation of gut microbiota by chondroitin sulfate and its oligosaccharide. Int. J. Biol. Macromol. 89 (2016), 489–498.
36. Shang, Q., Yin, Y., Zhu, L., Li, G., Yu, G., Wang, X., Degradation of chondroitin sulfate by the gut microbiota of Chinese individuals. Int. J. Biol. Macromol. 86 (2016), 112–118.
37. Shang, Q., Song, G., Zhang, M., Shi, J., Xu, C., Hao, J., Li, G., Yu, G., Dietary fucoidan improves metabolic syndrome in association with increased Akkermansia population in the gut microbiota of high-fat diet-fed mice. J. Funct. Foods 28 (2017), 138–146.
38. Shojaee-Aliabadi, S., Hosseini, H., Mohammadifar, M.A., Mohammadi, A., Ghasemlou, M., Ojagh, S.M., Hosseini, S.M., Khaksar, R., Characterization of antioxidant-antimicrobial κ-carrageenan films containing Satureja hortensis essential oil. Int. J. Biol. Macromol. 52 (2013), 116–124.
39. Sokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L.G., Gratadoux, J.J., Blugeon, S., Bridonneau, C., Furet, J.P., Corthier, G., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA 105 (2008), 16731–16736.
40. Swidsinski, A., Dörffel, Y., Loening-Baucke, V., Theissig, F., Rückert, J.C., Ismail, M., Rau, W.A., Gaschler, D., Weizenegger, M., Kühn, S., et al. Acute appendicitis is characterized by local invasion with Fusobacterium nucleatum/necrophorum. Gut 60 (2010), 34–40.
41. Tobacman, J.K., Bhattacharyya, S., Borthakur, A., Dudeja, P.K., The carrageenan diet: not recommended. Science 321 (2008), 1040–1041.
42. Tobacman, J.K., Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ. Health. Persp. 109 (2001), 983–994.
43. Uno, Y., Omoto, T., Goto, Y., Asai, I., Nakamura, M., Maitani, T., Molecular weight and fecal excreted quantity of carrageenan administered to rats in blended feed. Jpn. J. Food Chem. 8 (2001), 83–93.
44. Wang, F.F., Yao, Z., Wu, H.G., Zhang, S.X., Zhu, N.N., Gai, X., Antibacterial activities of kappa-carrageenan oligosaccharides. Appl. Mech. Mater. 108 (2011), 194–199.
45. Watson, D.B., Public health and carrageenan regulation: a review and analysis. J. Appl. Phycol. 20 (2008), 505–513.
46. Weiner, M.L., Food additive carrageenan: part II: a critical review of carrageenan in vivo safety studies. Crit. Rev. Toxicol. 44 (2014), 244–269.
47. Weiner, M.L., Parameters and pitfalls to consider in the conduct of food additive research: carrageenan as a case study. Food Chem. Toxicol. 87 (2016), 31–44.
48. Zhang, Z., Wu, X., Cao, S., Wang, L., Wang, D., Yang, H., Feng, Y., Wang, S., Li, L., Caffeic acid ameliorates colitis in association with increased Akkermansia population in the gut microbiota of mice. Oncotarget, 7, 2016, 31790.
49. Zhu, Y., Lin, X., Zhao, F., Shi, X., Li, H., Li, Y., Zhu, W., Xu, X., Li, C., Zhou, G., Meat, dairy and plant proteins alter bacterial composition of rat gut bacteria. Sci. Rep., 5, 2015, 15220.
50. Zou, Y., Lin, J., Li, W., Wu, Z., He, Z., Huang, G., Wang, J., Ye, C., Cheng, X., Ding, C., et al. Huangqin-tang ameliorates dextran sodium sulphate-induced colitis by regulating intestinal epithelial cell homeostasis, inflammation and immune response. Sci. Rep., 6, 2016, 39299.